Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons

R. Flisiak, D. Zarębska-Michaluk, E. Ciupkeviciene, S. Drazilova, S. Frankova, I. Grgurevic, B. Hunyady, P. Jarcuska, L. Kupčinskas, M. Makara, G. Saulite-Vanaga, M. Simonova, J. Sperl, I. Tolmane, A. Vince

. 2022 ; 14 (3) : . [pub] 20220226

Language English Country Switzerland

Document type Journal Article, Review

In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017-2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019355
003      
CZ-PrNML
005      
20250402154123.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/v14030482 $2 doi
035    __
$a (PubMed)35336889
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Flisiak, Robert $u Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, Poland $1 https://orcid.org/0000000333941635
245    10
$a HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons / $c R. Flisiak, D. Zarębska-Michaluk, E. Ciupkeviciene, S. Drazilova, S. Frankova, I. Grgurevic, B. Hunyady, P. Jarcuska, L. Kupčinskas, M. Makara, G. Saulite-Vanaga, M. Simonova, J. Sperl, I. Tolmane, A. Vince
520    9_
$a In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017-2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.
650    12
$a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
650    12
$a hepatitida C $x diagnóza $x epidemiologie $x prevence a kontrola $7 D006526
650    _2
$a lidé $7 D006801
650    _2
$a pandemie $x prevence a kontrola $7 D058873
650    _2
$a věznice $7 D011330
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Zarębska-Michaluk, Dorota $u Department of Infectious Diseases, Jan Kochanowski University, 25-317 Kielce, Poland $1 https://orcid.org/0000000309381084
700    1_
$a Ciupkeviciene, Egle $u Department of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, Lithuania
700    1_
$a Drazilova, Sylvia $u 2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, Slovakia
700    1_
$a Fraňková, Soňa $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000214625920 $7 xx0329475
700    1_
$a Grgurevic, Ivica $u Department of Gastroenterology, Hepatology and Clinical Nutrition, University of Zagreb, University Hospital Dubrava, 10000 Zagreb, Croatia $1 https://orcid.org/0000000305203483
700    1_
$a Hunyady, Bela $u Department of Gastroenterolgy, Somogy Megyei Kaposi Mór Oktató Kórház, H7400 Kaposvár, Hungary $u First Department of Internal Medicine, University of Pécs, H7624 Pécs, Hungary
700    1_
$a Jarcuska, Peter $u 2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, Slovakia
700    1_
$a Kupčinskas, Limas $u Department of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, Lithuania $1 https://orcid.org/0000000286899023
700    1_
$a Makara, Michael $u Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Saint Laszlo Hospital, 5-7. Albert Florian Street, H1097 Budapest, Hungary
700    1_
$a Saulite-Vanaga, Gunita $u Out-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, Latvia
700    1_
$a Simonova, Marieta $u Department of HPB Surgery and Transplantology, Clinic of Gastroenterology, Military Medical Academy, 1606 Sofia, Bulgaria
700    1_
$a Sperl, Jan $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech Republic $1 https://orcid.org/0000000186192610 $7 xx0071614
700    1_
$a Tolmane, Ieva $u Out-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, Latvia
700    1_
$a Vince, Adriana $u Department of Infectious Diseases, Medical School University of Zagreb, University Hospital of Infectious Diseases, 10000 Zagreb, Croatia
773    0_
$w MED00177099 $t Viruses $x 1999-4915 $g Roč. 14, č. 3 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35336889 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20250402154119 $b ABA008
999    __
$a ok $b bmc $g 1822800 $s 1170598
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 3 $e 20220226 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...